Cardiac Disease and Stroke
A surgical device company involved in the testing and design of novel medical devices. Research and training include the evaluation of minimally invasive medical devices for the treatment of cardiac diseases and the safe instruction of physicians in their use. This research could improve therapies and treatments for cardiac patients. This type of testing and training is a necessary step to improve the skills for practicing surgeons improve recovery for patients.
A minimally invasive surgery center involved in research and development of anastomotic devices for cardiac surgery. One of the most important parts of a Coronary Artery Bypass Graft operation is the suturing of bypass conduits onto the coronary arteries distal to the area of blockage. Typically these bypass grafts are hand sutured onto the heart. This facility is using knowledge of wire technology to develop an Anastomotic device that will not only decrease the time needed to complete the anastomosis but may result in a better quality anastomosis that has reproducible results.
Saphenous and Femoral Veins were used in the evaluation of a drug used to treat vein graft procedure. This research will help inform appropriate use of the drug for patients with arterial disease and are in need of arterial bypass grafts.
Medical research and device evaluation regarding minimally invasive aortic stents and grafts. The goal is to develop new technology for the treatment of chronic total occlusions in coronary arteries leading to safer, more effective technologies that improve patient outcomes.
Surgical education to perform atherectomy. This is a minimally invasive technique to treat peripheral artery disease (PAD) by removing atherosclerosis (plaque) from blood vessels.
Improved treatment options for cardiac patients requiring coronary artery bypass graft (CABG) surgery, including minimally invasive recovery of the greater saphenous vein.
Pacemaker research and improvements to better treat cardiac arrhythmias, including a leadless implant.
Use of heart specimens to develop 3-D computer modeling/mapping aimed at better prevention, treatment and understanding of numerous cardiac diseases.
Comparison between the binding effects of certain drugs on healthy and diseased arteries to develop new treatments for peripheral artery disease (PAD).
Training on new techniques and devices to perform arterial stenting aimed at combating peripheral artery disease (PAD).
Development of devices to better treat patients experiencing chronic heart failure (congestive heart failure or CHF).
Heart anatomy training for practicing cardiac surgeons.
Development of medical devices to treat patients with heavily calcified arteries.
Minimally invasive cardiac surgical techniques to reduce hospital stays, recovery times and pain.
The development of minimally invasive technology for the treatment of chronic total occlusions in coronary arteries (CTO). This is a complete blockage of a coronary artery resulting in decreased blood flow. As part of the research and development process, the performance of devices is evaluated using cardiac tissue. The research will improve the ability to design and develop safe and effective devices for the treatment of the disorder leading to improved outcomes for patients.
Research on the tensile strength and wall thickness of human hearts and lungs to develop devices to aid in the treatment of atrial fibrillation (A-fib). Recent research has shown that errant electrical signals can travel up the pulmonary veins into the heart causing irregular or erratic heart beats.
Cardiac tissue utilized for the study of mitral regurgitation. Mitral valve regurgitation is a condition in which the heart valve does not close properly allowing for the flow of blood backward in the heart. It makes the function of the heart inefficient, leading to patients becoming tired and out of breath. If not treated, it can ultimately lead to heart failure. Through these studies researchers hope to develop better treatments for patients.